Banco Bilbao Vizcaya Argentaria S.A. Buys 2,514 Shares of Tenet Healthcare Corporation $THC

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Tenet Healthcare by 80.6%, acquiring an additional 2,514 shares, bringing its total holdings to 5,635 shares, valued at approximately $757,000.
• Tenet Healthcare's stock increased by 1.2%, with a current market cap of $15.87 billion and earnings per share of $4.02 for the latest quarter, surpassing estimates.
• Institutional investors now own 95.44% of Tenet Healthcare's stock, with notable increases in holdings from firms like Dimensional Fund Advisors and Boston Partners in the first quarter.

Banco Bilbao Vizcaya Argentaria S.A. boosted its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 80.6% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 5,635 shares of the company's stock after buying an additional 2,514 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Tenet Healthcare were worth $757,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of THC. Dimensional Fund Advisors LP boosted its stake in shares of Tenet Healthcare by 12.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company's stock worth $225,297,000 after purchasing an additional 181,667 shares during the period. Nuveen LLC purchased a new position in shares of Tenet Healthcare during the first quarter valued at approximately $218,549,000. Boston Partners raised its holdings in shares of Tenet Healthcare by 692.9% in the first quarter. Boston Partners now owns 1,162,642 shares of the company's stock worth $156,318,000 after buying an additional 1,016,010 shares during the period. AQR Capital Management LLC lifted its stake in shares of Tenet Healthcare by 20.8% during the 4th quarter. AQR Capital Management LLC now owns 872,117 shares of the company's stock worth $110,087,000 after acquiring an additional 150,361 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Tenet Healthcare by 22.0% during the 4th quarter. Northern Trust Corp now owns 848,049 shares of the company's stock valued at $107,049,000 after acquiring an additional 152,671 shares during the period. Institutional investors own 95.44% of the company's stock.

Tenet Healthcare Stock Up 1.2%

Tenet Healthcare stock opened at $179.57 on Friday. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.39. The firm has a market cap of $15.87 billion, a P/E ratio of 11.50, a P/E/G ratio of 0.77 and a beta of 1.52. The business has a fifty day moving average of $168.67 and a two-hundred day moving average of $149.64. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $185.25.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, topping the consensus estimate of $2.84 by $1.18. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.The firm had revenue of $5.27 billion during the quarter, compared to analyst estimates of $5.16 billion. During the same period in the previous year, the company posted $2.31 EPS. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. On average, analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analyst Ratings Changes

THC has been the subject of several research analyst reports. Bank of America lifted their target price on Tenet Healthcare from $165.00 to $180.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. The Goldman Sachs Group upped their target price on shares of Tenet Healthcare from $134.00 to $154.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Wolfe Research downgraded shares of Tenet Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Royal Bank Of Canada increased their price objective on Tenet Healthcare from $183.00 to $189.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their target price on Tenet Healthcare from $190.00 to $200.00 and gave the company an "overweight" rating in a research report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $191.88.

Insiders Place Their Bets

In other news, EVP Lisa Y. Foo sold 8,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president owned 20,878 shares of the company's stock, valued at $3,748,227.34. The trade was a 27.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard W. Fisher sold 836 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $173.16, for a total transaction of $144,761.76. Following the completion of the sale, the director owned 11,292 shares of the company's stock, valued at approximately $1,955,322.72. This trade represents a 6.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,989 shares of company stock worth $5,369,512. Insiders own 0.81% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.